<scp>INnoVative</scp> trial design for testing the Efficacy, Safety and Tolerability of 6‐month treatment with incretin‐based therapy to prevent type 1 <scp>DIAbetes</scp> in autoantibody positive participants: A protocol for three parallel double‐blind, randomised controlled trials ( <scp>INVESTDIA</scp> )-Reference-Cited by-同舟云学术

INnoVative trial design for testing the Efficacy, Safety and Tolerability of 6‐month treatment with incretin‐based therapy to prevent type 1 DIAbetes in autoantibody positive participants: A protocol for three parallel double‐blind, randomised controlled trials ( INVESTDIA )

Published:2022-07-22 Issue:10 Volume:39 Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Kero Jukka¹²³,Koskenniemi Jaakko J.¹²³,Karsikas Sara²,Pokka Tytti⁴⁵,Lou Olivia⁶,Toppari Jorma¹³,Veijola Riitta⁴⁵^ORCID

Affiliation:

1. Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine University of Turku Turku Finland

2. Department of Paediatrics Turku University Hospital Turku Finland

3. Centre for Population Health Research University of Turku and Turku University Hospital Turku Finland

4. Department for Children and Adolescents Oulu University Hospital Oulu Finland

5. Department of Paediatrics, PEDEGO Research Unit MRC Oulu, University of Oulu Oulu Finland

6. JDRF New York New York USA

Funder

Juvenile Diabetes Research Foundation International

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14913

Reference28 articles.

1. Type 1 diabetes

2. Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children

3. Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S.

4. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretins beyond type 2 diabetes;Diabetologia;2023-08-08